Flamel Technologies

Since the acquisition of Éclat, we have implemented a balanced business model allowing Flamel to commercialize niche branded (Bloxiverz®® and Vazculep®) and generic pharmaceutical products in the U.S. and other countries as appropriate, and blend novel, high-value internally developed products with our drug delivery and capabilities. Flamel’s new model allows us now to select, develop, seek approval for, and commercialize niche branded products mainly in the U.S. and most of the opportunities are self-funded. By adopting this revised strategy, the Company makes itself less dependent on the often changing strategies of partners in the future. Nevertheless, Flamel is still exploring development, supply and licensing opportunities for either its drug delivery platforms or its proprietary products with carefully selected third parties, but, unlike our historical operations, will not be dependent completely on those partnerships to create revenue and profit opportunities.
Type
Public
HQ
Vénissieux, FR
Founded
1990
Size (employees)
109 (est)
Website
flamel.com
Flamel Technologies was founded in 1990 and is headquartered in Vénissieux, FR

Flamel Technologies Office Locations

Flamel Technologies has an office in Vénissieux

Flamel Technologies Metrics

Flamel Technologies Financial Metrics

Net income (2015)

$40.7 m

Market capitalization (18-Nov-2016)

$432.2 m

Closing share price (18-Nov-2016)

$10.8

Cash (31-Dec-2015)

$65.1 m
Flamel Technologies's current market capitalization is $432.2 m.
FY, 2015

R&D expense

$25.6 m

General and administrative expense

$21.7 m

Operating expense total

$47.3 m

EBIT

$71.4 m

Interest expense

($1.4 m)

Pre tax profit

$78.4 m

Income tax expense

$37.7 m

Net Income

$40.7 m
FY, 2015

Cash

$65.1 m

Current Assets

$166.3 m

PP&E

$2.6 m

Goodwill

$18.5 m

Total Assets

$215 m

Accounts Payable

$612 k

Current Liabilities

$48.8 m

Additional Paid-in Capital

$364 m

Retained Earnings

($279.8 m)

Total Equity

$67.9 m

Financial Leverage

3.2 x
FY, 2015

Net Income

$40.7 m

Depreciation and Amortization

$13.1 m

Cash From Operating Activities

$84.3 m

Purchases of PP&E

($1.6 m)

Cash From Investing Activities

($31.7 m)

Cash From Financing Activities

($23.8 m)

Interest Paid

$4.7 m

Flamel Technologies Market Value History

Flamel Technologies Company Life

You may also be interested in